Troponin I Level and Mortality in Acute Abdominal Surgery

Sponsor
Nordsjaellands Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05933837
Collaborator
(none)
341
1
36
9.5

Study Details

Study Description

Brief Summary

The goal of this prospective cohort study is to estimate the incidence of myocardial injury after non-cardiac surgery (MINS) in patients undergoing acute high-risk abdominal surgery.

MINS is defined as at least one increased single measurement of plasma troponin I (TnI). TnI-dynamic is defined as either two succeeding measurements of TnI > 59 ng/l with an increase/fall of more than 20%, or by one measurements of TnI > 59 ng/l with a succeeding measurement of TnI < 59 ng/l and a decrease of more than 50%.

Participants will have plasma TnI measured 6-12 hours postoperatively and on each of the following four postoperative days. Follow-up will be minimum one year after surgery.

The aim of the study is to determine:
  • The incidence of MINS within the first four postoperative days

  • The incidence of dynamic TnI changes

  • The association between MINS and dynamic TnI changes respectively and all-course short-term mortality

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Troponin I

Detailed Description

Gastrointestinal tract perforation, bowel ischemia and bowel obstruction are considered acute high-risk abdominal disorders, often requiring emergency surgery. Myocardial injury after non-cardiac surgery (MINS) is a frequent but often unrecognized postoperative complication. MINS is associated with an increased risk of other cardiac complications and 30-day mortality. However, the literature on MINS is mainly regarding patients undergoing a wide range of elective or acute surgical procedures, and we do not know if the dynamic TnI-criteria used for acute myocardial injury has any association with mortality in patients with MINS.

This study aims to estimate the incidence of MINS in patients undergoing AHA surgery, and the association between the short-term mortality and MINS defined as a single increased measurement of TnI and as TnI dynamics respectively.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
341 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Association Between Troponin I Levels and Mortality Among Patients Undergoing Acute High-risk Abdominal Surgery - a Cohort Study
Actual Study Start Date :
Mar 1, 2019
Actual Primary Completion Date :
Feb 28, 2021
Actual Study Completion Date :
Feb 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients with MINS

Troponin I level equal to or above 59 ng/L

Diagnostic Test: Troponin I
Measurements of plasma Troponin I 6-12 hours and on the first four postoperative days after surgery.

Patients without MINS

Troponin I level under 59 ng/L

Diagnostic Test: Troponin I
Measurements of plasma Troponin I 6-12 hours and on the first four postoperative days after surgery.

Outcome Measures

Primary Outcome Measures

  1. The incidence of MINS within the first four postoperative days [The first four postoperative days]

    Postoperative troponin I level equal to or above 59 ng/L

Secondary Outcome Measures

  1. The incidence of dynamic plasma Troponin I changes [The first four postoperative days]

    Patients with postoperative troponin I level equal to or above 59 ng/L and a change of +20%

Other Outcome Measures

  1. The association between MINS and all-course mortality within 30 days, 90 days, and 1 year [30-day, 90-day and 1-year]

    MINS defined as troponin I equal to or above 59 ng/L and mortality as yes/no

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years or older

  • Patients undergoing acute high-risk abdominal surgery

Exclusion Criteria:
  • Patients with microscopic perforations in colonic diverticulitis managed with laparoscopic lavage or drainage

  • If further treatment postoperatively was assessed as futile and terminated immediately after surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Copenhagen University Hospital - North Zealand Hillerød Denmark 3400

Sponsors and Collaborators

  • Nordsjaellands Hospital

Investigators

  • Study Chair: Claus A Bertelsen, Nordsjaellands Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Charlotte Tiffanie Bendtz Kanstrup, PhD, MD, Nordsjaellands Hospital
ClinicalTrials.gov Identifier:
NCT05933837
Other Study ID Numbers:
  • P-2020-507
First Posted:
Jul 6, 2023
Last Update Posted:
Jul 6, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Charlotte Tiffanie Bendtz Kanstrup, PhD, MD, Nordsjaellands Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2023